The Call to Action is an international petition that urges policy-makers and all other relevant stakeholders to give high priority to quality treatment and care for patients with rare cancers.
- Late or incorrect diagnosis
- Lack of access to appropriate therapies and clinical expertise
- Very limited number of clinical studies due to the small number of patients
RCE calls for new criteria to be used in clinical trials on rare cancer treatments.
A range of publications that can browsed online by all ESMO members and downloaded for offline use.